Transaction · 0001231919-26-000457

Ra Capital Management, L.P.

RA CAPITAL MANAGEMENT, L.P., DIR, reported a transaction classified as unknown at Hemab Therapeutics Holdings, Inc. involving 221188.000000 shares. Reported holdings after the transaction were 221188.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
COAGHemab Therapeutics Holdings, Inc.
Trade date
May 04, 2026
Filing date
May 06, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded221kPrice unknown
Holdings after221kIndirect · See footnotes
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

COAG price since this filing

Daily closing prices, with the filing date and available return windows
COAG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code C
Identifier
0001231919-26-000457
Common Stock
Transaction date
May 04, 2026
Filed May 06, 2026, 11:16 PM · 2d delay
Shares
221,188 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
221,188 sh
Indirect · See footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Increase
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initi…

  2. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus II Fund, L.P. (the "Nexus Fund II") and RA Capital Nexus IV Fu…

  3. F3

    Held directly by the Fund.

  4. F4

    Held directly by Nexus Fund II.

  5. F5

    Held directly by Nexus Fund IV.

  6. F6

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.9994 inclusive. The Reporting Persons undertake to…

  7. F7

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.495 to $24.455 inclusive. The Reporting Persons undertake to…

  8. F8

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.505 to $25.00 inclusive. The Reporting Persons undertake to…

Original filing · 0001231919-26-000457
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

COAG